Migraine Clinical Trials in New York

Showing 81-100 of 135 trials

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

NCT04089761

Nerivio™ is an FDA-authorized remote electrical neuromodulation (REN) device for the acute treatment of migraine with or without aura in patients 18 years old or above who do not have chronic migraine. The device delivers transcutaneous electrical stimulation to the upper arm to induce conditioned pain modulation (CPM) that activates a descending endogenous analgesic mechanism. This is a prospective, single arm, open label, multicenter trial of the safety and efficacy of Nerivio™ for the acute treatment of migraine in adolescents The study will be conducted in three phases: Phase I - Run-in: Phase II - Treatment phase: Phase III (optional) - Free-use

Acute Migraine

Theranica60 participantsStarted Oct 2019

Aurora, Colorado, United States • Hialeah, Florida, United States • Miami, Florida, United States +9 more locations

TERMINATEDNA< 1 mile

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

NCT01775735

The primary objective of this study is to evaluate the safety and efficacy of occipital nerve stimulation (ONS) using the Boston Scientific Corporation (BSC) Precision™ System in the management of intractable chronic migraine, when used in conjunction with anti-migraine medications.

Migraine Disorders

Boston Scientific Corporation28 participantsStarted Apr 2013

Valencia, California, United States • Chicago, Illinois, United States • Chicago, Illinois, United States +7 more locations

Safety and Efficacy of Nerivio™ for the Acute Treatment of Migraine in Adolescents

Occipital Nerve Stimulation (ONS) for Migraine: OPTIMISE

Migraine Trials in Other Cities

Efficacy, Safety, and Tolerability of Multiple Dosing Regimens of Oral Atogepant (AGN-241689) in Episodic Migraine Prevention

Intranasal Lidocaine to Treat Pediatric Migraine in the Emergency Department

Trial of Comprehensive Migraine Intervention

Efficacy, Safety, and Tolerability of Oral Ubrogepant in the Acute Treatment of Migraine

Study in Participants With Acute Migraines Headaches

Musculoskeletal Impairment in Headaches Attributed to Rhinosinusitis

Safety and Efficacy of NPS 1776 in the Acute Treatment of Migraine Headaches

A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

A Study of M207 With Intranasal Zolmitriptan in Healthy Volunteers

An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine

A Study of Galcanezumab (LY2951742) in Adults With Treatment-Resistant Migraine

ESCAPE Migraine Trial

PREMIUM Migraine Trial

Topical Bimatoprost in the Treatment of Migraine

Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy

Pharmacokinetic Single Dose Study of Oral Lasmiditan in Participants With Normal and Impaired Hepatic Function

Efficacy and Safety of BGG492 in the Treatment of Migraine

Other Conditions in New York